Neo Ivy Capital Management raised its stake in Royalty Pharma plc ( NASDAQ:RPRX – Get Rating ) by 10.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,014 shares of the biopharmaceutical company's stock after buying an additional 660 shares during the quarter. Neo Ivy Capital Management's holdings in Royalty Pharma were worth $277,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in RPRX.

https://www.dailypolitical.com/2023/06/16/neo-ivy-capital-management-has-277000-stock-position-in-royalty-pharma-plc-nasdaqrprx.html

#dailypolitical